|
|
Singapore builds 140 mln USD microbial manufacturing plant |
 |
+ |
- |
13:45, June 29, 2007 |
U.S.-based biotechnology giant Genentech started to build a 140 million U.S. dollars microbial manufacturing facility here Thursday, another shot in the arm for Singapore's biologics industry.
When it is fully operational, the plant will employ about 100 staff members and produce two cutting-edge cancer drugs Avastin and Herceptin, as well as Lucentis, a treatment for wet age-related macular degeneration.
S. Iswaran, Singapore's Minister of State for Trade and Industry, praised it a strategic investment for Singapore's fast growing biopharmaceuticals industry.
Singapore has identified the biomedical sciences as a key pillar for its manufacturing industry, and been trying to put in place the requisite policies and resources to make the country a conducive location for world-class biomedical sciences activities including pharmaceutical manufacturing.
According to the minister, Singapore now is host to eight of the world's top pharmaceutical companies that have cumulatively set up 24 chemical-based pharmaceutical manufacturing facilities here.
Iswaran noted that Singapore has embarked on three major initiatives, pertaining to the development of manpower, capabilityand engineering support, to optimally position Singapore for this growth industry.
Source: Xinhua
|
|
|
Comment
Tell A Friend
Print Format
Save Article